Biotech · Public company · Radnor, PA, US

Mineralys Therapeutics, Inc.

Ticker MLYS · SEC CIK 0001933414

Track this companyFree. Adds Mineralys Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials61 recruiting or active

Pipeline programs6From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline6

lorundrostatPhase 3 · HypertensionClinicalTrials.gov · fetched Nov 12, 2026
lorundrostat Dose 1Phase 3 · HypertensionClinicalTrials.gov · fetched Nov 12, 2026
lorundrostat Dose 2Phase 3 · HypertensionClinicalTrials.gov · fetched Nov 12, 2026
LorundrostatPhase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
MLS-101 (Part I)Phase 2 · Hypertension, RenalClinicalTrials.gov · fetched Nov 12, 2026
MLS-101 (Part II)Phase 2 · Hypertension, RenalClinicalTrials.gov · fetched Nov 12, 2026

A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and HypertensionPHASE2 · COMPLETED · started Feb 28, 2025ClinicalTrials.gov NCT06785454 · fetched Nov 12, 2026
Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With AlbuminuriaPHASE2 · COMPLETED · started Dec 14, 2023ClinicalTrials.gov NCT06150924 · fetched Nov 12, 2026
Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant HypertensionPHASE3 · COMPLETED · started Nov 22, 2023ClinicalTrials.gov NCT06153693 · fetched Nov 12, 2026
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With HypertensionPHASE3 · ACTIVE_NOT_RECRUITING · started Jul 14, 2023ClinicalTrials.gov NCT05968430 · fetched Nov 12, 2026
A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication RegimenPHASE2 · COMPLETED · started Mar 13, 2023ClinicalTrials.gov NCT05769608 · fetched Nov 12, 2026
Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled HypertensionPHASE2 · COMPLETED · started Jul 1, 2021ClinicalTrials.gov NCT05001945 · fetched Nov 12, 2026